Kopczyński, Janusz
Suligowska, Agnieszka
Niemyska, Kornelia
Pałyga, Iwona
Walczyk, Agnieszka
Gąsior-Perczak, Danuta
Kowalik, Artur
Hińcza, Kinga
Mężyk, Ryszard
Góźdź, Stanisław
Kowalska, Aldona
Funding for this research was provided by:
Ministerstwo Nauki i Szkolnictwa Wyższego
Article History
First Online: 31 March 2020
Compliance with Ethical Standards
: The study plan was approved by the Bioethics Committee of the Regional Chamber of Physicians of Kielce. Patients’ written informed consent was obtained when molecular studies were performed. All patients with NIFTP tumors provided written consent for molecular testing for the <i>BRAF</i> p.V600E and <i>hTERT</i> promoter mutations.
: The authors declare that they have no conflict of interest.